CIA
NVAX icon

Cape Investment Advisory’s Novavax NVAX Stock Holding History

Cape Investment Advisory’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-300
Closed -$1.89K – 1067
2025
Q2 		$1.89K Buy
+300
New +$1.99K ﹤0.01% 949
2023
Q4 		– Sell
-100
Closed -$724 – 1188
2023
Q3 		$724 Hold
100
– – ﹤0.01% 856
2023
Q2 		$743 Hold
100
– – ﹤0.01% 839
2023
Q1 		$693 Buy
+100
New +$920 ﹤0.01% 896

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cape Investment Advisory's NVAX Position: Q3 2025 in Review

Cape Investment Advisory sold out of Novavax (NVAX) in Q3 2025, closing a stake of 300 shares — an estimated $1.89K sold.

Cape Investment Advisory first reported a position in NVAX in Q1 2023 and held it in 4 quarters. The position peaked at $1.89K in Q2 2025. 249 funds tracked by Wall St. Rank hold NVAX as of Q3 2025.

  • Cape Investment Advisory reported no remaining Novavax position as of Q3 2025 after selling out during the quarter.
  • Cape Investment Advisory sold 300 Novavax shares in Q3 2025, an estimated $1.89K.
  • Cape Investment Advisory first reported a position in Novavax in Q1 2023 and held it in 4 quarters.
  • Cape Investment Advisory's Novavax position peaked at $1.89K in Q2 2025.
  • 249 funds tracked by Wall St. Rank held Novavax as of Q3 2025.

Based on Cape Investment Advisory's 13F filing for Q3 2025, filed 29 Dec 2025.